In clinical trials, tirzepatide showed robust glucose-lowering and weight-reducing effects: in the SURPASS-2 Phase 3 trial, once-weekly doses (5, 10, or 15 mg) led to HbA1c reductions of up to 2.46% and weight loss of up to 12.4 kg over 40 weeks in patients with type 2 diabetes
"Patients treated for obesity with semaglutide or trizepatide lost less weight on average in a regular clinical setting compared to what is observed in randomized clinical trial," lead investigator Hamlet Gasoyan said in a news release
High Potency Formula Each serving delivers 3,000mg of L-Carnitine in an easy-to-take liquid shot, designed for maximum convenience
The test reveals predispositions in peptide genetic pathwaysnot exact medication response or safety outcomesand should be interpreted with clinical expertise to support safer treatment planning
"After just a few months, I feel more energetic and focused than I have in years
'I was dry heaving and I was fighting the urge to throw up all day